BRISTOL MYERS SQUIBB CO
Datakwaliteit: 100%
CELG-RI
NYSE
Manufacturing
Chemicals
€ 0,09
▼
€ 0,01
(-9,09%)
Marktkapitalisatie: 201,86 M
Prijs
€ 0,10
Marktkapitalisatie
201,86 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 0,96% annually over 5 years — modest growth
ROE of 39,20% indicates high profitability
Debt/Equity of 2,87 — high leverage
Generating 12,85 B in free cash flow
P/E of 0,03 — trading at a low valuation
PEG of 0,14 suggests growth is underpriced
Groei
Revenue Growth (5Y)
0,96%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-0,22%
Earnings (1Y)N/A
FCF Growth (3Y)0,76%
Kwaliteit
Return on Equity
39,20%
Boven sectorgemiddelde (-53,53%)
ROICN/A
Net Margin14,64%
Op. MarginN/A
Veiligheid
Debt / Equity
2,87
Boven sectorgemiddelde (0,31)
Current Ratio1,27
Interest CoverageN/A
Waardering
PE (TTM)
0,03
Boven sectorgemiddelde (-1,48)
P/B Ratio0,01
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,0 | -1,5 |
| P/B | 0,0 | 1,6 |
| ROE % | 39,2 | -53,5 |
| Net Margin % | 14,6 | -41,5 |
| Rev Growth 5Y % | 1,0 | 1,8 |
| D/E | 2,9 | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 |
€ 3,55
N/A – N/A
|
48,66 B | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,22% | Revenue Growth (3Y) | 3,48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -6,24% |
| Revenue Growth (5Y) | 0,96% | Earnings Growth (5Y) | 0,21% |
| Profitability | |||
| Revenue (TTM) | 48,19 B | Net Income (TTM) | 7,05 B |
| ROE | 39,20% | ROA | 7,36% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | 14,64% | Free Cash Flow (TTM) | 12,85 B |
| ROIC | N/A | FCF Growth (3Y) | 0,76% |
| Safety | |||
| Debt / Equity | 2,87 | Current Ratio | 1,27 |
| Interest Coverage | N/A | Asset Turnover | 0,50 |
| Working Capital | 7,49 B | Tangible Book Value | -23,66 B |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0,03 | Forward P/E | N/A |
| P/B Ratio | 0,01 | P/S Ratio | 0,00 |
| PEG Ratio | 0,14 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6363,29% | ||
| Market Cap | 201,86 M | Enterprise Value | 37,70 B |
| Per Share | |||
| EPS (Diluted TTM) | 3,46 | Revenue / Share | 23,64 |
| FCF / Share | 6,30 | OCF / Share | 6,94 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | 2,62% |
| EPS CAGR (10Y) | 3,01% | ||
| Efficiency | |||
| CapEx / Revenue | 2,72% | FCF Conversion | 182,10% |
| SBC-Adj. FCF | 12,30 B | Growth Momentum | -1,18 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48,19 B | 48,30 B | 45,01 B | 46,16 B | 46,39 B |
| Net Income | 7,05 B | -8,95 B | 8,03 B | 6,33 B | 6,99 B |
| EPS (Diluted) | 3,46 | -4,41 | 3,86 | 2,95 | 3,12 |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9,95 B | 11,16 B | 9,30 B | 9,51 B | 11,35 B |
| SG&A Expenses | 7,27 B | 8,41 B | 7,77 B | 7,81 B | 7,69 B |
| D&A | 4,01 B | 9,60 B | 9,76 B | 10,28 B | 10,69 B |
| Interest Expense | 1,89 B | 1,95 B | 1,17 B | 1,23 B | 1,33 B |
| Income Tax | 2,27 B | 554,00 M | 400,00 M | 1,37 B | 1,08 B |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,04 B | 92,60 B | 95,16 B | 96,82 B | 109,31 B |
| Total Liabilities | 71,53 B | 76,22 B | 65,67 B | 65,70 B | 73,31 B |
| Shareholders' Equity | 18,47 B | 16,34 B | 29,43 B | 31,06 B | 35,95 B |
| Total Debt | 47,09 B | 51,48 B | 42,65 B | 43,22 B | 49,32 B |
| Cash & Equivalents | 10,21 B | 10,35 B | 11,46 B | 9,12 B | 13,98 B |
| Current Assets | 29,39 B | 29,78 B | 31,77 B | 27,27 B | 33,26 B |
| Current Liabilities | 23,42 B | 23,77 B | 22,26 B | 21,89 B | 21,87 B |
{"event":"ticker_viewed","properties":{"ticker":"CELG-RI","listing_kind":"stock","pathname":"/stocks/celg-ri","exchange":"NYSE","country":"US"}}